It has been reported earlier that curcumin blocked the lipopolysaccharide-induced EMT procedures through the modulation of the expression of motility and invasiveness marker, e.g., vimentin and E-cadherin, in MDA-MB-231 breast cancer cells. The gene discussed is CDH1; the disease is breast carcinoma.